Arm looks wildly overvalued at nearly a $500 billion market cap, about 96x sales and 150x next-twelve-month earnings. The euphoria shows in @steve2bacon calling it the easiest hold ever. x.com 

Arm's valuation carries an absurd premium for the architecture layer. It trades at 91.9x EV/sales, far above its historical range, as Wall Street prices it as the mandatory royalty tollbooth for every custom AI chip. EDA leaders Cadence, at 30.1x, and Synopsys, at 21.2x, trade near the low end of their historical bands, priced like mature utilities, as the market stacks almost all the scarcity premium into Arm. x.com 

Arm's low blended royalties leave pricing and mix leverage that makes earnings look massively understated at 110x forward P/E. It collects about 7 cents per chip overall, versus $1 on compute and networking chips and $0.85-$0.90 on smartphones. An 8-cent bump to 15 cents per chip is a hypothetical $5-6 billion royalty-revenue scenario, which would be pure cash. Mix shift and price increases are coming, though royalties may not double. x.com  x.com 

Arm is still expensive at about 40x revenue with only 20% growth, so it has not fallen enough. x.com 

Arm Holdings is expensive against its earnings, trading at 92x forward earnings versus a typical 38x for chipmakers. At 38x next year's $3.05 EPS, fair value runs roughly $102-$130, so at $281.30 buyers pay about 116% over fair value. This is a levels-only view from reported earnings and revenue estimates, with no fundamental work. x.com 

Arm's fundamentals remain extremely strong, but component shortages could cost it margin as it moves into manufacturing. It confirmed accelerating demand of up to $2B for its new AGI CPU, yet has components for only about 50% of it, so meeting demand may mean paying higher prices. Management expects CPU demand to rise about 4x by 2030, which means about 4x the component needs too. At a valuation priced for perfection, the market may not accept any hit to growth or margins. x.com  x.com 

Arm is heavily overvalued: at about $240B it trades above 100x forward P/E and roughly 50x sales, already pricing in about 26x earnings five years out. That rests on FY2031 targets of $25B revenue, $15B of it from its own AGI CPU silicon starting from zero, and $9.00 EPS. Momentum is real, with Q1 revenue up 22% and the AGI CPU order book doubling to $2B+. But chip sales dilute ~98% IP gross margins to ~40-50%, and reliance on TSMC wafers adds execution risk the multiple leaves no room for. … Show more

Arm Holdings looks unattractive because its nearly 300 P/E ratio is difficult to justify against only 22% year-over-year revenue growth. x.com 

Arm is well positioned in the AI CPU stack as agentic AI drives massive CPU demand and x86 loses ground. Its new AGI CPU, its first production silicon, comes with a five-year goal of about $15 billion in chip revenue, $25 billion total and more than $9 in EPS, roughly 38% annual growth, though meaningful revenue is not expected until fiscal 2028. Royalties from third-party CPUs like Nvidia's Vera add another path. That TAM expansion could take out its roughly $185 all-time high within two years. … Show more

Arm is hard to justify over Nvidia, which is cheaper and growing faster. Arm trades at 44x sales and 112x earnings with 28% two-year sales growth and 32% EPS growth, while Nvidia trades at 11x sales and 20x earnings with 60%+ growth in both. There is more to an investment case than these figures. x.com